Johan Åkerstedt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Johan Åkerstedt has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Ragnhild Tønnessen
Norwegian Veterinary Institute Ås Norway
7 shared publications - Britt Gjerset
Norwegian Veterinary Institute, Ås, Norway
6 shared publications - Cathrine Arnason Bøe
Norwegian Veterinary Institute Ås Norway
6 shared publications - Silje Granstad
Norwegian Veterinary Institute, Ås, Norway
6 shared publications - Bjørnar Ytrehus
Norwegian Veterinary Institute, Ås, Norway
4 shared publications - Olav Hungnes
Norwegian Institute of Public Health, Oslo, Norway
4 shared publications
Latest Publications
- Open Access
Highly Pathogenic Avian Influenza Viruses H5N1 and H5N5 in Red Foxes ( Vulpes vulpes ) in Norway during 2022-2024
Since 2020, highly pathogenic avian influenza (HPAI) A(H5Nx) clade 2.3.4.4b viruses have spread globally, causing extensive outbreaks in domestic and wild birds. Increased circulation has resulted in frequent spillover to mammals, and occasional mammal-to-mammal transmission. Although human infections remain rare, the zoonotic potential of these viruses continues to be a public health concern. We investigated six cases of HPAI in red foxes ( Vulpes vulpes ) in Norway during 2022-2024 and identified infections with H5N1 and H5N5 viruses. Pathological and virological investigations demonstrated systemic infection, with prominent lesions in the brain and/or lungs. Phylogenetic analyses showed high similarity between viruses detected in foxes and those concurrently circulating in wild birds. The mammalian adaptation marker PB2:E627K was identified in one H5N1 virus and as a minority variant in a second H5N1 virus.
Open AccessHighly Pathogenic Avian Influenza Viruses H5N1 and H5N5 in Red Foxes ( Vulpes vulpes ) in Norway during 2022-2024
Since 2020, highly pathogenic avian influenza (HPAI) A(H5Nx) clade 2.3.4.4b viruses have spread globally, causing extensive outbreaks in domestic and wild birds. Increased circulation has resulted in frequent spillover to mammals, and occasional mammal-to-mammal transmission. Although human infections remain rare, the zoonotic potential of these viruses continues to be a public health concern. We investigated six cases of HPAI in red foxes ( Vulpes vulpes ) in Norway during 2022-2024 and identified infections with H5N1 and H5N5 viruses. Pathological and virological investigations demonstrated systemic infection, with prominent lesions in the brain and/or lungs. Phylogenetic analyses showed high similarity between viruses detected in foxes and those concurrently circulating in wild birds. The mammalian adaptation marker PB2:E627K was identified in one H5N1 virus and as a minority variant in a second H5N1 virus.
- Open Access
Serological Evidence of Widespread Exposure to H5 Avian Influenza Virus in Arctic Foxes in Svalbard, Norway
The continued circulation of H5 clade 2.3.4.4b highly pathogenic avian influenza virus (HPAIV) has caused extensive mortality in wild bird populations worldwide with increasing spillover to mammals. In 2022, H5 HPAIV emerged in Svalbard, Norway, with subsequent detections in wild birds, walruses, polar bears, and arctic foxes. To understand the population-level exposure among Svalbard arctic foxes, we analysed body fluids from carcasses trapped in 2006-2015 (n = 56), 2023-2024 (n = 112), and 2024-2025 (n = 94) for antibodies to H5 avian influenza (anti- H5), influenza A nucleoprotein (anti-NP), and neuraminidase subtypes using ELISAs, haemagglutination inhibition (HI), and a multiplex assay. Only three samples from 2006-2015 tested positive for anti-H5 and were interpreted as false positives. In 2023-2024, seropositivity for anti-H5 was high (95%), supported by a lower anti-NP seropositivity (85%) and antibody profiles consistent with mixed H5N1 (42%) and H5N5 (52%) exposure. In 2024-2025, anti-H5 and anti-NP seroprevalences remained high (83% and 57%), with H5N5 (87%) exposure predominating over H5N1 (3%). A subset of anti-H5-positive samples tested positive by HI (2023-2024: 30%; 2024-2025: 14%). Juveniles with exposure limited to the previous season had higher odds of anti-H5 seropositivity in 2023-2024 than in 2024-2025 (OR 5.5). Analysis of paired lung extracts from a subset of individuals (n = 63) yielded results concordant with body fluids, using an indirect anti-H5 ELISA adapted for carnivores. Our findings demonstrate widespread H5 virus exposure. Together with occasional reports of progression to fatal HPAI, this highlights the need for continued population monitoring to evaluate ecological consequences.
Open AccessSerological Evidence of Widespread Exposure to H5 Avian Influenza Virus in Arctic Foxes in Svalbard, Norway
The continued circulation of H5 clade 2.3.4.4b highly pathogenic avian influenza virus (HPAIV) has caused extensive mortality in wild bird populations worldwide with increasing spillover to mammals. In 2022, H5 HPAIV emerged in Svalbard, Norway, with subsequent detections in wild birds, walruses, polar bears, and arctic foxes. To understand the population-level exposure among Svalbard arctic foxes, we analysed body fluids from carcasses trapped in 2006-2015 (n = 56), 2023-2024 (n = 112), and 2024-2025 (n = 94) for antibodies to H5 avian influenza (anti- H5), influenza A nucleoprotein (anti-NP), and neuraminidase subtypes using ELISAs, haemagglutination inhibition (HI), and a multiplex assay. Only three samples from 2006-2015 tested positive for anti-H5 and were interpreted as false positives. In 2023-2024, seropositivity for anti-H5 was high (95%), supported by a lower anti-NP seropositivity (85%) and antibody profiles consistent with mixed H5N1 (42%) and H5N5 (52%) exposure. In 2024-2025, anti-H5 and anti-NP seroprevalences remained high (83% and 57%), with H5N5 (87%) exposure predominating over H5N1 (3%). A subset of anti-H5-positive samples tested positive by HI (2023-2024: 30%; 2024-2025: 14%). Juveniles with exposure limited to the previous season had higher odds of anti-H5 seropositivity in 2023-2024 than in 2024-2025 (OR 5.5). Analysis of paired lung extracts from a subset of individuals (n = 63) yielded results concordant with body fluids, using an indirect anti-H5 ELISA adapted for carnivores. Our findings demonstrate widespread H5 virus exposure. Together with occasional reports of progression to fatal HPAI, this highlights the need for continued population monitoring to evaluate ecological consequences.
- Open Access
- 17 August 2026
- Published by Microbiology Society in Journal of General Virology
- Vol. 107 (8) , 002305
Multiple introductions of highly pathogenic avian influenza viruses into the High Arctic: Svalbard and Jan Mayen, 2022–2025
Between 2022 and 2025, highly pathogenic avian influenza viruses (HPAIVs) of clade 2.3.4.4b, including four distinct H5 Eurasian (EA) genotypes, were detected in wild birds and mammals in the Svalbard Archipelago and on the island of Jan Mayen. We describe their epidemiology and genomic characteristics to improve understanding of HPAIV occurrence and transmission in the High Arctic. The initial cases in 2022 occurred during summer and involved a glaucous gull ( Larus hyperboreus ) and great skuas ( Stercorarius skua ) on Svalbard and Jan Mayen, representing the first detections of HPAIVs in the High Arctic. Three HPAIV genotypes were identified: EA-2020-C (H5N1), EA-2021-AB (H5N1) and EA-2021-I (H5N5). In 2023, HPAIVs were detected in a broader range of bird species and retrospectively in an Atlantic walrus ( Odobenus rosmarus rosmarus ) as reported by another research group. Genotypes identified in 2023 were EA-2020-C (H5N1), EA-2021-I (H5N5) and EA-2022-BB (H5N1). No cases were reported in 2024. In 2025, EA-2021-I (H5N5) was detected in Arctic foxes ( Vulpes lagopus ) on Svalbard, without preceding detections in wild birds. The foxes exhibited neurological symptoms and necropsy of one individual revealed the presence of feathers in its stomach. All sequenced viruses from the Arctic foxes uniquely carried the combination of PB2-E627K and PB1-H115Q, previously associated with mammalian adaptation. The detection of multiple genotypes indicates repeated and independent introductions of HPAIVs into these regions. The co-circulation of genetically distinct virus strains in areas of high bird density further suggests that Arctic breeding grounds may facilitate local viral amplification, reassortment and subsequent dissemination along migratory flyways, including transcontinental spread.
- 17 August 2026
- Published by Microbiology Society in Journal of General Virology
- Vol. 107 (8) , 002305
Open AccessMultiple introductions of highly pathogenic avian influenza viruses into the High Arctic: Svalbard and Jan Mayen, 2022–2025
Between 2022 and 2025, highly pathogenic avian influenza viruses (HPAIVs) of clade 2.3.4.4b, including four distinct H5 Eurasian (EA) genotypes, were detected in wild birds and mammals in the Svalbard Archipelago and on the island of Jan Mayen. We describe their epidemiology and genomic characteristics to improve understanding of HPAIV occurrence and transmission in the High Arctic. The initial cases in 2022 occurred during summer and involved a glaucous gull ( Larus hyperboreus ) and great skuas ( Stercorarius skua ) on Svalbard and Jan Mayen, representing the first detections of HPAIVs in the High Arctic. Three HPAIV genotypes were identified: EA-2020-C (H5N1), EA-2021-AB (H5N1) and EA-2021-I (H5N5). In 2023, HPAIVs were detected in a broader range of bird species and retrospectively in an Atlantic walrus ( Odobenus rosmarus rosmarus ) as reported by another research group. Genotypes identified in 2023 were EA-2020-C (H5N1), EA-2021-I (H5N5) and EA-2022-BB (H5N1). No cases were reported in 2024. In 2025, EA-2021-I (H5N5) was detected in Arctic foxes ( Vulpes lagopus ) on Svalbard, without preceding detections in wild birds. The foxes exhibited neurological symptoms and necropsy of one individual revealed the presence of feathers in its stomach. All sequenced viruses from the Arctic foxes uniquely carried the combination of PB2-E627K and PB1-H115Q, previously associated with mammalian adaptation. The detection of multiple genotypes indicates repeated and independent introductions of HPAIVs into these regions. The co-circulation of genetically distinct virus strains in areas of high bird density further suggests that Arctic breeding grounds may facilitate local viral amplification, reassortment and subsequent dissemination along migratory flyways, including transcontinental spread.
- Open Access
Multiple Introductions of Highly Pathogenic Avian Influenza Viruses into the High Arctic: Svalbard and Jan Mayen, 2022–2025
Between 2022 and 2025, highly pathogenic avian influenza viruses (HPAIVs) of clade 2.3.4.4b, including four distinct H5 Eurasian (EA) genotypes, were detected in wild birds and mammals in the Svalbard Archipelago and on the island of Jan Mayen. We describe their epidemiology and genomic characteristics to improve understanding of HPAIV occurrence and transmission in the High Arctic. The initial cases in 2022 occurred during summer and involved a glaucous gull ( Larus hyperboreus ) and great skuas ( Stercorarius skua ) on Svalbard and Jan Mayen, representing the first detections of HPAIVs in the High Arctic. Three HPAIV genotypes were identified: EA-2020-C (H5N1), EA-2021-AB (H5N1), and EA-2021-I (H5N5). In 2023, HPAIVs were detected in a broader range of bird species, and retrospectively in an Atlantic walrus reported by another research group ( Odobenus rosmarus rosmarus ). Genotypes identified in 2023 were EA-2020-C (H5N1), EA-2021-I (H5N5), and EA-2022-BB (H5N1). No cases were reported in 2024. In 2025, EA-2021-I (H5N5) was detected in Arctic foxes ( Vulpes lagopus ) on Svalbard, without preceding detections in wild birds. The foxes exhibited neurological symptoms, and necropsy of one individual revealed the presence of feathers in its stomach. All sequenced viruses from the Arctic foxes uniquely carried the combination of PB2-E627K and PB1-H115Q, which is associated with mammalian adaptation. The detection of multiple genotypes indicates repeated and independent introductions of HPAIVs into these regions. The co-circulation of genetically distinct virus strains in areas of high bird density further suggests that Arctic breeding grounds may facilitate local viral amplification, reassortment, and subsequent dissemination along migratory flyways, including transcontinental spread. Data summary: The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files. Influenza A whole genome sequences generated through this study are available under the GISAID accession numbers found in Table 1. All genome sequences and associated metadata supporting the findings of this study can be accessed through the persistent digital object identifier https://doi.org/10.55876/gis8.260211rq . Table 1. Detections of highly pathogenic avian influenza virus (HPAIV) in wild birds and mammals sampled in the Svalbard Archipelago and on Jan Mayen from January 1 st , 2022, to August 31 st , 2025.:
Open AccessMultiple Introductions of Highly Pathogenic Avian Influenza Viruses into the High Arctic: Svalbard and Jan Mayen, 2022–2025
Between 2022 and 2025, highly pathogenic avian influenza viruses (HPAIVs) of clade 2.3.4.4b, including four distinct H5 Eurasian (EA) genotypes, were detected in wild birds and mammals in the Svalbard Archipelago and on the island of Jan Mayen. We describe their epidemiology and genomic characteristics to improve understanding of HPAIV occurrence and transmission in the High Arctic. The initial cases in 2022 occurred during summer and involved a glaucous gull ( Larus hyperboreus ) and great skuas ( Stercorarius skua ) on Svalbard and Jan Mayen, representing the first detections of HPAIVs in the High Arctic. Three HPAIV genotypes were identified: EA-2020-C (H5N1), EA-2021-AB (H5N1), and EA-2021-I (H5N5). In 2023, HPAIVs were detected in a broader range of bird species, and retrospectively in an Atlantic walrus reported by another research group ( Odobenus rosmarus rosmarus ). Genotypes identified in 2023 were EA-2020-C (H5N1), EA-2021-I (H5N5), and EA-2022-BB (H5N1). No cases were reported in 2024. In 2025, EA-2021-I (H5N5) was detected in Arctic foxes ( Vulpes lagopus ) on Svalbard, without preceding detections in wild birds. The foxes exhibited neurological symptoms, and necropsy of one individual revealed the presence of feathers in its stomach. All sequenced viruses from the Arctic foxes uniquely carried the combination of PB2-E627K and PB1-H115Q, which is associated with mammalian adaptation. The detection of multiple genotypes indicates repeated and independent introductions of HPAIVs into these regions. The co-circulation of genetically distinct virus strains in areas of high bird density further suggests that Arctic breeding grounds may facilitate local viral amplification, reassortment, and subsequent dissemination along migratory flyways, including transcontinental spread. Data summary: The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files. Influenza A whole genome sequences generated through this study are available under the GISAID accession numbers found in Table 1. All genome sequences and associated metadata supporting the findings of this study can be accessed through the persistent digital object identifier https://doi.org/10.55876/gis8.260211rq . Table 1. Detections of highly pathogenic avian influenza virus (HPAIV) in wild birds and mammals sampled in the Svalbard Archipelago and on Jan Mayen from January 1 st , 2022, to August 31 st , 2025.:
- Open Access
- 1 January 2026
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2026 (1)
Highly Pathogenic Avian Influenza A (H5N1) Caused Mass Death Among Black‐Legged Kittiwakes ( Rissa tridactyla ) in Norway, 2023
In 2023, highly pathogenic avian influenza (HPAI) heavily affected gulls in Europe. In July, a mass mortality event was reported in the black‐legged kittiwake ( Rissa tridactyla ) breeding colony at Ekkerøy in Northern Norway. The cause was confirmed to be infection with the HPAI H5N1 clade 2.3.4.4b virus, genotype EA‐2022‐BB. We describe the outbreak in kittiwakes, including pathological and virological investigations, and discuss the management and zoonotic potential. With more than 15,000 dead birds reported, we estimate that the outbreak caused a reduction in the kittiwake population at Ekkerøy of at least 50%. Diseased birds exhibited neurological signs. Necropsies of 10 birds revealed a peracute fatal systemic disease, with severe lesions in the brain and pancreas co‐localizing with viral RNA and antigen. Vascular expression of α2,3‐linked sialic acids (SAs) and viral RNA/antigen may reflect hematogenous viral spread. Further studies should investigate the long‐term impact of HPAI on kittiwake populations.
- 1 January 2026
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2026 (1)
Open AccessHighly Pathogenic Avian Influenza A (H5N1) Caused Mass Death Among Black‐Legged Kittiwakes ( Rissa tridactyla ) in Norway, 2023
In 2023, highly pathogenic avian influenza (HPAI) heavily affected gulls in Europe. In July, a mass mortality event was reported in the black‐legged kittiwake ( Rissa tridactyla ) breeding colony at Ekkerøy in Northern Norway. The cause was confirmed to be infection with the HPAI H5N1 clade 2.3.4.4b virus, genotype EA‐2022‐BB. We describe the outbreak in kittiwakes, including pathological and virological investigations, and discuss the management and zoonotic potential. With more than 15,000 dead birds reported, we estimate that the outbreak caused a reduction in the kittiwake population at Ekkerøy of at least 50%. Diseased birds exhibited neurological signs. Necropsies of 10 birds revealed a peracute fatal systemic disease, with severe lesions in the brain and pancreas co‐localizing with viral RNA and antigen. Vascular expression of α2,3‐linked sialic acids (SAs) and viral RNA/antigen may reflect hematogenous viral spread. Further studies should investigate the long‐term impact of HPAI on kittiwake populations.
- Open Access
Highly Pathogenic Avian Influenza A(H5N1) Caused Mass Death among Black-legged Kittiwakes ( Rissa tridactyla ) in Norway, 2023
In 2023, highly pathogenic avian influenza (HPAI) heavily affected gulls in Europe. In July, a mass mortality event was reported in the Black-legged Kittiwake ( Rissa tridactyla ) breeding colony at Ekkerøy in Northern Norway. The cause was confirmed to be infection with the HPAI H5N1 clade 2.3.4.4b virus, genotype EA-2022-BB. We describe the outbreak in Kittiwakes, including pathological and virological investigations, and discuss the management and zoonotic potential. With more than 15,000 dead birds reported, we estimate that the outbreak caused a reduction in the Kittiwake population at Ekkerøy of at least 50%. Diseased birds exhibited neurological signs. Necropsy of ten birds revealed a peracute fatal systemic disease, with severe lesions in the brain and pancreas co-localizing with the presence of viral RNA and antigen. Vascular expression of α2,3-linked sialic acids and viral RNA/antigen may reflect hematogenous virus spread. Further studies should investigate the long-term impact of HPAI on Kittiwake populations.
Open AccessHighly Pathogenic Avian Influenza A(H5N1) Caused Mass Death among Black-legged Kittiwakes ( Rissa tridactyla ) in Norway, 2023
In 2023, highly pathogenic avian influenza (HPAI) heavily affected gulls in Europe. In July, a mass mortality event was reported in the Black-legged Kittiwake ( Rissa tridactyla ) breeding colony at Ekkerøy in Northern Norway. The cause was confirmed to be infection with the HPAI H5N1 clade 2.3.4.4b virus, genotype EA-2022-BB. We describe the outbreak in Kittiwakes, including pathological and virological investigations, and discuss the management and zoonotic potential. With more than 15,000 dead birds reported, we estimate that the outbreak caused a reduction in the Kittiwake population at Ekkerøy of at least 50%. Diseased birds exhibited neurological signs. Necropsy of ten birds revealed a peracute fatal systemic disease, with severe lesions in the brain and pancreas co-localizing with the presence of viral RNA and antigen. Vascular expression of α2,3-linked sialic acids and viral RNA/antigen may reflect hematogenous virus spread. Further studies should investigate the long-term impact of HPAI on Kittiwake populations.
- Open Access
- 1 November 2024
- Published by Microbiology Society in Journal of General Virology
- Vol. 105 (11) , 002035
Emergence of highly pathogenic avian influenza viruses H5N1 and H5N5 in white-tailed eagles, 2021–2023
Highly pathogenic avian influenza (HPAI) poses a substantial threat to several raptors. Between 2021 and 2023, HPAI viruses (HPAIVs) of the Goose/Guangdong lineage H5 clade 2.3.4.4b became widespread in wild birds in Norway, and H5N1 and H5N5 viruses were detected in 31 white-tailed eagles (Haliaeetus albicilla, WTEs). Post-mortem examinations of four WTEs revealed no macroscopic pathological findings. Microscopic examinations showed the presence of myocardial and splenic necroses and a few lesions in the brain.In situhybridization revealed the presence of the virus in several organs, suggesting a multisystemic infection. The detection of HPAIV H5N5 in a WTE in February 2022 marked the first recorded occurrence of this subtype in Norway. Since then, the virus has persisted, sporadically being detected in WTEs and other wild bird species. Phylogenetic analyses reveal that at least two distinct incursions of HPAIV H5N1 Eurasian (EA) genotype C affected WTEs, likely introduced by migratory birds from Eurasia and seabirds entering from Western and Central Europe. Some WTE isolates from 2021 to 2022 clustered with those from Canada and Ireland, aligning with the transatlantic spread of H5N1. Others were related to the 2021 mass mortality of great skuas in the UK or outbreaks in seabird populations, including gannets, gulls and terns, during 2022 in the North Sea region. This suggests that the WTEs were likely preying on the affected birds. Our study highlights that WTEs can act as sentinels for some HPAIV strains, but the absence of several known circulating genotypes in WTEs suggests varying pathogenic effects on this species.
- 1 November 2024
- Published by Microbiology Society in Journal of General Virology
- Vol. 105 (11) , 002035
Open AccessEmergence of highly pathogenic avian influenza viruses H5N1 and H5N5 in white-tailed eagles, 2021–2023
Highly pathogenic avian influenza (HPAI) poses a substantial threat to several raptors. Between 2021 and 2023, HPAI viruses (HPAIVs) of the Goose/Guangdong lineage H5 clade 2.3.4.4b became widespread in wild birds in Norway, and H5N1 and H5N5 viruses were detected in 31 white-tailed eagles (Haliaeetus albicilla, WTEs). Post-mortem examinations of four WTEs revealed no macroscopic pathological findings. Microscopic examinations showed the presence of myocardial and splenic necroses and a few lesions in the brain.In situhybridization revealed the presence of the virus in several organs, suggesting a multisystemic infection. The detection of HPAIV H5N5 in a WTE in February 2022 marked the first recorded occurrence of this subtype in Norway. Since then, the virus has persisted, sporadically being detected in WTEs and other wild bird species. Phylogenetic analyses reveal that at least two distinct incursions of HPAIV H5N1 Eurasian (EA) genotype C affected WTEs, likely introduced by migratory birds from Eurasia and seabirds entering from Western and Central Europe. Some WTE isolates from 2021 to 2022 clustered with those from Canada and Ireland, aligning with the transatlantic spread of H5N1. Others were related to the 2021 mass mortality of great skuas in the UK or outbreaks in seabird populations, including gannets, gulls and terns, during 2022 in the North Sea region. This suggests that the WTEs were likely preying on the affected birds. Our study highlights that WTEs can act as sentinels for some HPAIV strains, but the absence of several known circulating genotypes in WTEs suggests varying pathogenic effects on this species.
- Open Access
- 1 March 2019
- Published by Springer Nature in BMC Veterinary Research
- Vol. 15 (1) , 1-8
Specificity of serological test for detection of tuberculosis in cattle, goats, sheep and pigs under different epidemiological situations
Serum antibody detection has potential as a complementary diagnostic tool in animal tuberculosis (TB) control, particularly in multi-host systems. The objective of the present study was to assess the specificity (Sp) of an enzyme-linked immunosorbent assay (ELISA) based on the new multiprotein complex P22 for the detection of specific antibodies against the Mycobacterium tuberculosis complex (MTC) in the four most relevant domestic animals acting as MTC hosts: cattle, goat, sheep and pig. We used sera from an officially TB-free (OTF) country, Norway, and from a non-OTF one, Spain. The samples included sera from goats that had been vaccinated against M. avium subsp. paratuberculosis (MAP) and sheep from a herd in which Corynebacterium pseudotuberculosis had been isolated. In cattle, the Sp ranged from 92.5 (IC95% 90.7–94) to 99.4% (IC95% 98.3–99.8) depending on the cut-off used and the origin of the samples (Spain or Norway). Sp in cattle (cut-off point 100) was significantly higher (P < 0.05) for Norwegian samples. By contrast, Sp in goats was consistently low at the 100 cut-off [30.9 (CI95%23.4–39.5)-78% (CI95% 68.9–85)]. A higher cut-off of 150 improved Sp in Norwegian goats [97% (CI95% 91.6–99)], but still yielded a poor Sp of 56.1% (CI95% 47.3–64.6) in Spanish goats. In Norway at the 100 cut-off the Sp was 58.3 (CI95% 42.2–72.9) and 90.6% (CI95% 81–95.6) in MAP vaccinated and non-vaccinated goats, respectively, indicating interference due to MAP vaccination. Sp in sheep was between 94.4 (CI95% 91.7–96.3) and 100% (CI95% 96.3–100) depending on the cut-off and country, and no diagnostic interference due to infection with C. pseudotuberculosis was recorded. Sp in pigs was 100%, regardless the cut-off point applied, and no significant differences were observed between pigs from Norway and from Spain. Due to its excellent Sp in pigs and acceptable Sp in cattle and sheep, this ELISA may constitute a suitable option for TB screening at herd level, particularly in OTF-countries.
- 1 March 2019
- Published by Springer Nature in BMC Veterinary Research
- Vol. 15 (1) , 1-8
Open AccessSpecificity of serological test for detection of tuberculosis in cattle, goats, sheep and pigs under different epidemiological situations
Serum antibody detection has potential as a complementary diagnostic tool in animal tuberculosis (TB) control, particularly in multi-host systems. The objective of the present study was to assess the specificity (Sp) of an enzyme-linked immunosorbent assay (ELISA) based on the new multiprotein complex P22 for the detection of specific antibodies against the Mycobacterium tuberculosis complex (MTC) in the four most relevant domestic animals acting as MTC hosts: cattle, goat, sheep and pig. We used sera from an officially TB-free (OTF) country, Norway, and from a non-OTF one, Spain. The samples included sera from goats that had been vaccinated against M. avium subsp. paratuberculosis (MAP) and sheep from a herd in which Corynebacterium pseudotuberculosis had been isolated. In cattle, the Sp ranged from 92.5 (IC95% 90.7–94) to 99.4% (IC95% 98.3–99.8) depending on the cut-off used and the origin of the samples (Spain or Norway). Sp in cattle (cut-off point 100) was significantly higher (P < 0.05) for Norwegian samples. By contrast, Sp in goats was consistently low at the 100 cut-off [30.9 (CI95%23.4–39.5)-78% (CI95% 68.9–85)]. A higher cut-off of 150 improved Sp in Norwegian goats [97% (CI95% 91.6–99)], but still yielded a poor Sp of 56.1% (CI95% 47.3–64.6) in Spanish goats. In Norway at the 100 cut-off the Sp was 58.3 (CI95% 42.2–72.9) and 90.6% (CI95% 81–95.6) in MAP vaccinated and non-vaccinated goats, respectively, indicating interference due to MAP vaccination. Sp in sheep was between 94.4 (CI95% 91.7–96.3) and 100% (CI95% 96.3–100) depending on the cut-off and country, and no diagnostic interference due to infection with C. pseudotuberculosis was recorded. Sp in pigs was 100%, regardless the cut-off point applied, and no significant differences were observed between pigs from Norway and from Spain. Due to its excellent Sp in pigs and acceptable Sp in cattle and sheep, this ELISA may constitute a suitable option for TB screening at herd level, particularly in OTF-countries.
- Open Access
- 1 September 2014
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 116 (1-2) , 37-46
Estimation of the probability of freedom from Bovine virus diarrhoea virus in Norway using scenario tree modelling
- 1 September 2014
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 116 (1-2) , 37-46
Open AccessEstimation of the probability of freedom from Bovine virus diarrhoea virus in Norway using scenario tree modelling
- Open Access
- 1 March 2004
- Published by Springer Nature in Acta Veterinaria Scandinavica
- Vol. 45 (1) , 19-26
Bacteriological Investigation of Infectious Keratoconjunctivitis in Norwegian Sheep
Contagious keratoconjunctivitis is a rather common disease in Norwegian sheep. Since the knowledge of its aetiology is limited, the present study was performed to determine the microorganisms involved. Local veterinarians throughout the country collected conjunctival swabs from both sick (n = 43) and healthy (n = 42) sheep on 15 farms with outbreaks of ovine keratoconjunctivitis, and further from healthy sheep (n = 50) on 17 farms not showing any signs of conjunctival disease. All samples were cultivated for bacteria and mycoplasma. Listeria monocytogenes was isolated from 3 cases (1%) in one single herd. Staphylococcus aureus (5%), Corynebacterium spp. (2%) and Escherichia coli (4%) were isolated only in herds with keratoconjunctivitis, but from both sick and healthy animals. Moraxella (Branhamella) ovis was isolated from 28% of sampled animals in affected herds and from 10% of sampled animals in healthy herds. The corresponding numbers for Moraxella spp. were 9%/12%, for Pseudomonas spp. 7%/8%, for Staphylococcus spp. 22//22%, for Bacillus spp. 12%/14%, for Micrococcus spp. 6%/2% and for Streptococcus/Enterococcus spp. 2%/2%. Mycoplasma conjunctivae was isolated from 16 animals with keratoconjunctivitis (37%) and from 3 animals without clinical signs (7%) in farms with keratoconjunctivitis. In farms without clinical signs of keratoconjunctivitis, M. conjunctivae was isolated in 4 animals (8%). To our knowledge, this is the first time M. conjunctivae has been isolated in Norway. Other predisposing agents found were Moraxella (Branhamella) ovis and Listeria monocytogenes. The etiological importance of different microorganisms in ovine keratoconjunctivitis seems to vary; some are probably only present as secondary invaders. Other possible causes of ovine keratoconjunctivitis in Norway, such as Chlamydia psittaci, remain to be investigated.
- 1 March 2004
- Published by Springer Nature in Acta Veterinaria Scandinavica
- Vol. 45 (1) , 19-26
Open AccessBacteriological Investigation of Infectious Keratoconjunctivitis in Norwegian Sheep
Contagious keratoconjunctivitis is a rather common disease in Norwegian sheep. Since the knowledge of its aetiology is limited, the present study was performed to determine the microorganisms involved. Local veterinarians throughout the country collected conjunctival swabs from both sick (n = 43) and healthy (n = 42) sheep on 15 farms with outbreaks of ovine keratoconjunctivitis, and further from healthy sheep (n = 50) on 17 farms not showing any signs of conjunctival disease. All samples were cultivated for bacteria and mycoplasma. Listeria monocytogenes was isolated from 3 cases (1%) in one single herd. Staphylococcus aureus (5%), Corynebacterium spp. (2%) and Escherichia coli (4%) were isolated only in herds with keratoconjunctivitis, but from both sick and healthy animals. Moraxella (Branhamella) ovis was isolated from 28% of sampled animals in affected herds and from 10% of sampled animals in healthy herds. The corresponding numbers for Moraxella spp. were 9%/12%, for Pseudomonas spp. 7%/8%, for Staphylococcus spp. 22//22%, for Bacillus spp. 12%/14%, for Micrococcus spp. 6%/2% and for Streptococcus/Enterococcus spp. 2%/2%. Mycoplasma conjunctivae was isolated from 16 animals with keratoconjunctivitis (37%) and from 3 animals without clinical signs (7%) in farms with keratoconjunctivitis. In farms without clinical signs of keratoconjunctivitis, M. conjunctivae was isolated in 4 animals (8%). To our knowledge, this is the first time M. conjunctivae has been isolated in Norway. Other predisposing agents found were Moraxella (Branhamella) ovis and Listeria monocytogenes. The etiological importance of different microorganisms in ovine keratoconjunctivitis seems to vary; some are probably only present as secondary invaders. Other possible causes of ovine keratoconjunctivitis in Norway, such as Chlamydia psittaci, remain to be investigated.